Literature DB >> 19638107

Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines.

Jean-Michel Guerit1, Aldo Amantini, Catherine Fischer, Peter W Kaplan, Oriano Mecarelli, Alfons Schnitzler, Emilio Ubiali, Piero Amodio.   

Abstract

By studying neuronal activity through neuronal electrogenesis, neurophysiological investigations provide a functional assessment of the nervous system and, therefore, has been used for quantitative assessment and follow-up of hepatic encephalopathy (HE). The different clinical neurophysiological approaches can be classified depending on the function to explore and their sensitivity to HE. The reliable techniques are those that reflect cortical function, i.e., cognitive-evoked potentials (EPs) (P300 paradigm), electroencephalogram (EEG), visual EPs (latency>100 ms) and somatosensory EPs (SEPs) (latency between 25 and 100 ms). Short-latency EPs (brainstem acoustic EPs, SEPs of a latency<25 ms) are in principle insensitive to HE, but can disclose brainstem conduction deficits due to oedema. SEPs and motor EPs can disclose myelopathies. Because of its parallelism to the clinical examination, clinical neurophysiology can complement the neurological examination: (i) to provide evidence of HE in patients who have normal consciousness; (ii) to rule out, at least under some conditions, disturbances of consciousness due to other causes (e.g. drug-induced disturbances, non-convulsive status epilepticus) with the reservation that the mildest degrees of encephalopathy might be associated with an EEG pattern similar to that induced by drugs; and (iii) to demonstrate the worsening or, conversely improvement, of HE in the follow-up period.

Entities:  

Mesh:

Year:  2009        PMID: 19638107     DOI: 10.1111/j.1478-3231.2009.02030.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  39 in total

Review 1.  Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.

Authors:  Lise L Gluud; Rebecca Jeyaraj; Marsha Y Morgan
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

Review 2.  Hepatic encephalopathy and sleepiness: an interesting connection?

Authors:  Sara Montagnese; Matteo Turco; Piero Amodio
Journal:  J Clin Exp Hepatol       Date:  2014-06-29

Review 3.  Challenges in diagnosing hepatic encephalopathy.

Authors:  K Weissenborn
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

4.  Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.

Authors:  Harry D Zacharias; Antony P Zacharias; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

5.  A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.

Authors:  Hanaa Mostafa El-Karaksy; Omneya Afifi; Azza Bakry; Ann Abdel Kader; Noha Saber
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

Review 6.  Hepatic Encephalopathy in the Hospitalized Patient: A Review for Hospitalists.

Authors:  Harleen Kaur Chela; Nishchayjit Basra; S Hasan Naqvi
Journal:  Mo Med       Date:  2019 Jul-Aug

Review 7.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

Review 8.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

9.  Effect of obstructive sleep apnea on the sleep architecture in cirrhosis.

Authors:  Matthew R Kappus; David J Leszczyszyn; Leonard Moses; Shekar Raman; Douglas M Heuman; Jasmohan S Bajaj
Journal:  J Clin Sleep Med       Date:  2013-03-15       Impact factor: 4.062

10.  The Influence of Finasteride on Mean and Relative Spectral Density of EEG Bands in Rat Model of Thioacetamide-Induced Hepatic Encephalopathy.

Authors:  D Mladenović; D Hrnčić; A Rašić-Marković; Dj Macut; O Stanojlović
Journal:  Neurotox Res       Date:  2016-03-07       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.